FindTrial
Sign In

Development and validation of a clinical nomogram for predicting IHD and morbidity in patients with pheochromocytoma surgery

Development and validation of a clinical nomogram for predicting IHD and morbidity in patients with pheochromocytoma surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020811
Enrollment
Unknown
Registered
2019-01-20
Start date
2019-01-17
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pheochromcytoma

Interventions

Group 2:without morbidity and IHD
Group 1:with morbidity and IHD

Sponsors

Department of Urology, ShengJing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The diagnosis of pheochromocytoma was confirmed by pathologic examination and patients who underwent unilateral either laparoscopic or open adrenalectomy were included. Clinical stage was localized (apparently benign) disease and American Society of Anesthesiologists (ASA) score was 1-3.

Exclusion criteria

Exclusion criteria: Patients with pheochromocytoma familial history, patients who converted to laparotomy, those who underwent bilateral adrenalectomy or surgery for ectopic pheochromocytoma were excluded.

Design outcomes

Primary

MeasureTime frame
morbidity;IHD;—

Countries

China

Contacts

Public ContactSong Bai

Department of Urology, ShengJing Hospital of China Medical University

baisongcmu@163.com+86 18940255568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026